Drug-target binding kinetics has recently attracted considerable interest in view of the potential predictive power for in vivo drug efficacy. The recently introduced antihistamine bilastine has a long duration of in vivo drug action, which outlasts pharmacological active bilastine concentrations in blood. To provide a molecular basis for the long duration of action, we explored the kinetics of bilastine binding to the human histamine H 1 receptor using [ 
Introduction
The therapeutic success of a variety of approved drugs has recently been related to their target residence time, which is a measure for the length of target-engagement (Copeland et al., 2006; Guo et al., 2014; Hoffmann et al., 2015; Lu and Tonge, 2010; Swinney, 2004) . Numerous second generation antihistamines have been shown to have a long residence time at the histamine H 1 receptor and their residence times correlate with the duration of antagonism after removal of these antihistamines in vitro (Bosma et al., 2017) . Also in vivo drug efficacy is postulated to be prolonged when drug-target binding outlasts the presence of pharmacologically active plasma concentrations (Dahl and Akerud, 2013 ). Interestingly, in vivo H 1 receptor antagonism by the second-generation antihistamines fexofenadine and levocetirizine only marginally decreased and is not in line with the much faster decline in their plasma concentrations, a phenomenon, which is also referred to as hysteresis (Schoepke et al., 2013) . As both fexofenadine and levocetirizine have a long residence time at the H 1 receptor (Gillard et al., 2002) , this pharmacodynamic drug property is likely to be implicated in the increased timespan of in vivo therapeutic effects of these antihistamines.
Bilastine (Fig. 1 ), a selective, second generation H 1 receptor -antihistamine, developed by FAES FARMA laboratories was approved for use in the European Union in 2010, and is currently being introduced into clinical practice in more than 100 Countries of the European Union, Africa, Latin America, Asia (including Japan) and Canada, for the symptomatic treatment of allergic rhinoconjunctivitis (perennial and seasonal) and urticaria in adults over 12 years (Togawa et al., 2016; Wang et al., 2016) . Recently bilastine has been approved for children aged 6-11 years. For adults, bilastine is presented at single oral dose of 20 mg per day and shows no signs of sedative side effects nor cardiotoxicity (Togawa et al., 2016; Wang et al., 2016) . Radioligand binding experiments conducted on human recombinant H 1 receptors, expressed in HEK293 cells demonstrated that bilastine has a good binding affinity (K i ) of 64 nM for the H 1 receptor (Corcóstegui et al., 2005) . Moreover, bilastine shows a half-life of 12 h after oral administration in man. Yet, bilastine still shows 60 -70% H 1 receptor antagonism 24 h after dosing, while plasma concentrations have decreased below pharmacologically active concentrations (Church, 2011; Togawa et al., 2016) . We hypothesize that a prolonged H 1 receptor target engagement (i.e. long residence time) is the molecular basis for the observed prolonged in vivo H 1 receptor antagonism by bilastine. Therefore, in this study the kinetics of H 1 receptor binding by bilastine and the time course of H 1 receptor antagonism was compared to the reference compounds fexofenadine and diphenhydramine ( Fig. 1) , which are prototypical long and short residence time antihistamines, respectively (Gillard et al., fexofenadine and bilastine were shown to have hysteresis of their pharmacological effect in vivo (Church, 2011; Schoepke et al., 2013) and have a similar clinical pharmacological profile (Yanai et al., 2017) .
Materials and methods

Materials
Fetal bovine serum (FBS) (#A15-101; GE Healthcare); penicillin/ streptomycin 100 × (#15140-122; GE healthcare); diphenhydramine hydrochloride (#D3630; Sigma Aldrich), fexofenadine hydrochloride (#Y0000789; Sigma Aldrich), probenecid (#P8761; Sigma Aldrich); mianserin was synthesized at the Vrije Universiteit Amsterdam and was fully characterized with respect to purity and identity; Hank's balanced salt solution (HBSS) (#14025-050; Thermo Fisher Scientific); Histamine. 
Test compounds
Bilastine, batch #4713J62 (purity 100%, HPLC) was supplied from FAES FARMA S. A. (April 28th, 2016) as a powder, whereas diphenhydramine hydrochloride (product D3630; Lot. MKBQ9569V; Sigma Aldrich) and fexofenadine hydrochloride (product Y0000789; Lot. 1.0; Sigma Aldrich) were obtained from Sigma Aldrich. All three test compounds were dissolved as 10 mM stock solutions in DMSO and diluted in buffer to the indicated concentrations, assuring that the final DMSO concentration in the assay is less than 1%.
Radioligand binding assays
Competition binding experiments
Radioligand binding assays were performed as recently described . Briefly, HEK293T cells were transiently transfected with the N-terminally HA-tagged histamine H 1 receptor and cells were collected two days post transfection and stored as cell pellets at −20°C until further experimentation. HEK293T cell pellets were thawed and resuspended in binding buffer (50 mM Na 2 HPO 4 and 50 mM KH 2 PO 4 mixed to pH 7.4 at 25°C) and subsequently homogenized by sonification. The [ radioligand. Incubations were performed under gentle agitation at 25°C. The binding reaction was terminated by rapid filtration through GF/C filters (filters were pre-soaked in 0.5% 750 kDa branched polyethylenimine for 30 min) and three rapid washes using ice cold wash buffer (50 mM Tris-HCl pH 7.4 at 4°C). The level of radioligand bound to the GF-C plate was determined by scintillation counting using Microscint-O and quantified with a Microbeta counter (Perkin-Elmer Life and Analytical Sciences, Inc., USA). A representative graph is shown of ≥ 3 experiments, which depicts the mean ± S.D. of n = 3. K i values were calculated from the measured IC 50 values (Graphpad Prism 6.0; Graphpad Software, Inc., CA, USA) using the Cheng-Prusoff equation (Cheng and Prusoff, 1973) .
for the H 1 receptor, used to calculate the K i of unlabelled ligands, was determined before (Kuhne et al., 2016) .
Competitive association experiments
The k on and k off values of the test compounds were determined by so-called competitive association experiments. HA-H 1 receptor expressing cell homogenate was co-incubated with a single concentration 2-3 nM [
3 H]mepyramine with and without three concentrations of each of the unlabelled antihistamines for various incubation times. Concentrations of antihistamines were selected to cause different levels of partial displacement of the radioligand within the 80 min incubation time for radioligand association. This typically results in concentrations of approximately 1-10 times the K i value for fast dissociating unlabelled ligands and 3 -30 times the K i value for slow dissociating unlabelled ligands. To determine the non-specific binding (i.e. binding at t = 0 min), radioligand and cell homogenate were co-incubated with a saturating concentration mianserin (10 −5 M). The level of radioligand binding was determined as described above. Representative graphs are shown of ≥ 3 experiment, which depict the mean ± S.D. of n = 2. Binding rate constants of the antihistamines were determined by nonlinear regression using the Motulsky-Mahan model, using Graphpad Prism 6.0 (Motulsky and Mahan, 1984) . The binding rate constants of ; k off : 0.22 min −1 ) needed to calculate the binding rate constants of unlabelled ligands were previously determined .
Recovery of histamine-induced calcium signaling in human HeLa cells
In this assay the histamine-induced, H 1 receptor -mediated intracellular Ca 2+ response was measured using the calcium responsive fluorescent dye Fluo-4 NW solution (Thermo Fisher Scientific, Waltham, USA). The recovery rate of histamine responsiveness was measured following inhibition by and washout of the antihistamines. This assay was recently validated and described in detail (Bosma et al., 2017) . Briefly, HeLa cells (endogenously expressing the H 1 receptor) were seeded in black clear bottom 96 well plate with 20,000 cells per R. Bosma et al. European Journal of Pharmacology 838 (2018) 107-111 well. All subsequently used solutions were pre-incubated to 37°C prior to supplementing them to the cells. Cells were pre-incubated with vehicle or a concentration of antihistamine that corresponds to 10 times the respective K i value. After 17 h incubation, cells were co-incubated using the same concentration of the respective antihistamine in Fluo4 NW solution for another hour after which the medium was aspirated and cells were washed 2 times with assay buffer (HBSS buffer supplemented with 20 mM HEPES and 2.5 mM probenecid). Finally, cells were incubated in assay buffer and subsequently stimulated with histamine (10 µM) after various incubation times. For each well, the fluorescent intensity was determined (excitation 494 nm; emission 516 nm) for the background signal, the peak response following histamine stimulation and the response after lysing the cells with 1.5% Triton-X-100. Peak intensities were normalized to background and Triton-X-100 induced signal, allowing comparison of the measured calcium mobilization between wells. The calcium response was further normalized to the average response of 10 µM histamine (100%), which was plotted against the time between washing away unbound antihistamines from the cells and stimulating the cells with histamine. The observed recovery (k rec ) rate was determined by fitting the data to a one-phase decay model in GraphPad Prism 6.0. The recovery time was calculated per experiment as the reciprocal of the k rec .
Results
Radioligand binding studies
As reported previously Kuhne et al., 2016) (Cheng and Prusoff, 1973) . Under equilibrium binding conditions bilastine and diphenhydramine show equal binding affinities, as reflected by the pK i values of 8.1 ± 0.1 (K i of 8.7 nM and 8.4 nM respectively). For fexofenadine, a slightly lower pK i value of 7.5 ± 0.1 (K i is 32 nM) was determined for its binding to the H 1 receptor (Table 1) .
Kinetics of H 1 receptor binding as determined by [ 3 H]mepyramine binding studies
To determine kinetic binding rate constants for the binding of the three antihistamines to the human H 1 receptor, [ 3 H]mepyramine was co-incubated for increasing incubation times with different concentrations of bilastine (Fig. 3A) , diphenhydramine (Fig. 3B) or fexofenadine (Fig. 3C) , respectively. In the presence of diphenhydramine, a gradual increase in radioligand binding to the H 1 receptor was observed, whereas in the presence of bilastine or fexofenadine, [ 3 H]mepyramine binding shows a clear overshoot at the early time points. Such an overshoot indicates that the antihistamine has considerable slower binding kinetics compared to the used radioligand [ 3 H]mepyramine. The kinetic association rate constant (k on ) and the kinetic dissociation rate constant (k off ) for the H 1 receptor binding of the unlabelled antihistamines were determined by fitting the competitive association curves to the Motulsky-Mahan model (Motulsky and Mahan, 1984) . From the kinetic binding rate constants, the binding affinity (pK d,calc = k off / k on ) and the residence time (RT = 1 / k off ) for H 1 receptor binding were calculated (Table 1) . Bilastine had a comparable residence time for binding the human H 1 receptor (73 min) as fexofenadine (60 min). Both second generation antihistamines had a > 100-fold higher residence time compared to the first generation antihistamine diphenhydramine which shows very rapid binding kinetics. The obtained pK i and pK d,calc values were comparable for all three ligands, indicating that the incubation time for displacement studies (4 h) was sufficient to reach equilibrium and to accurately determine the K i values.
Effect of H 1 receptor antagonists on histamine-induced calcium mobilization in Hela cells
To test whether the difference in residence times affected the time course of H 1 receptor antagonism by the three antihistamines, HeLa cells, endogenously expressing the human H 1 receptor, were pre-incubated overnight with a high concentration of each antihistamine to ensure high target occupancy. Unbound antihistamines were removed by wash steps and the histamine induced calcium mobilization in HeLa cells was measured over time to determine the recovery of the H 1 receptor responsiveness. As observed in Fig. 4 , the histamine induced calcium levels was constant over time if cells were pre-incubated without any antihistamine (Fig. 4, black circles) . Moreover, preincubation with short RT antagonist diphenhydramine (Fig. 4 , blue circles) did not inhibit the histamine induced calcium response after washout and the histamine responsiveness was almost immediately restored to control levels. In contrast, HeLa cells pre-incubated with fexofenadine or bilastine, showed prolonged inhibition of the receptor responsiveness for longer than 1 h after removal of unbound antihistamines (Fig. 4, red and green circles, respectively) . For each experiment, the data was fitted to a one-phase association model and the obtained k rec from this analysis (i.e. recovery rate of receptor signaling) was quantified by fitting the data to a one-phase association model (Table 2) . From this analysis, the recovery time of receptor signaling was calculated by taking the reciprocal of the k rec value, analogous to calculating the residence time from the k off value. It was recently shown that in this assay k rec values correlate with k off values of antihistamines as determined by radioligand binding studies (Bosma et al., 2017) .
In this experimental setup, bilastine showed a significantly slower recovery rate of receptor signaling than fexofenadine (Table 2 , Student t-test; P < 0.05). The recovery after preincubation with diphenhydramine was too rapid to calculate a meaningful k rec value (Table 2) . 
Discussion
Binding affinities of drugs have been used to predict the drug target occupancy, although such a prediction is only valid under equilibrium conditions. Yet, in vivo drug concentrations change rapidly and target affinity might thus be a poor predictor of the target occupancy and the resulting in vivo efficacy. The onset and offset of drug-target binding can be predicted instead by the ligand binding kinetics. The residence time (reciprocal of the k off value) is a measure for the length of the drugreceptor complex and it was postulated that the drug-target residence time is a better predictor of in vivo drug efficacy (Copeland et al., 2006; Guo et al., 2014; Hoffmann et al., 2015; Lu and Tonge, 2010; Swinney, 2004) .
For a set of first and second generation H 1 receptor -antihistamines, it was previously shown that compounds with similar binding affinity (as determined by equilibrium competition binding) could show dramatically different binding kinetics, and consequently different residence times (Bosma et al., 2017 Gillard et al., 2002) . Also in this study, bilastine and diphenhydramine are shown to have similar H 1 receptor binding affinities, but the two antihistamines display a more than 100-fold difference in their kinetic binding rate constants at the H 1 receptor. In contrast to diphenhydramine, bilastine was found to have a long residence time (RT = 73 min) at the human H 1 receptor and to dissociate slightly slower than fexofenadine (RT = 60 min).
The slow H 1 receptor dissociation of bilastine and fexofenadine was reflected in prolonged H 1 receptor antagonism, as measured using a previously described in vitro assay of histamine-induced calcium mobilization in HeLa cells (Bosma et al., 2017) . In comparison, in the same experimental setup no antagonism of the H 1 receptor was observed after washout of diphenhydramine, despite a similar binding affinity to bilastine. The residence time of antihistamines therefore better predicts the level of antagonism in this assay than their binding affinity.
In this study, the binding affinity of bilastine (K i = 8.7 nM) was found to be somewhat higher than previously reported (K i = 64 nM (Corcóstegui et al., 2005) ). In view of the observed slow binding R. Bosma et al. European Journal of Pharmacology 838 (2018) 107-111 kinetics of bilastine, this can be explained by the difference in incubation times. The 30 min incubation time in the earlier study might not have resulted in a complete equilibrium of binding of bilastine, leading to an underestimation of its binding affinity (Dowling and Charlton, 2006; Motulsky and Mahan, 1984) . Moreover, the K i determined in this study (240 min incubation time) matched well with the binding affinity calculated from the binding rate constants (Table 1 ).
In conclusion, bilastine is shown to have a long residence time at the human H 1 receptor as determined by [ 3 H]mepyramine competition association binding studies. Its residence time is similar to the residence time of fexofenadine, leading for both antihistamines to prolonged antagonism of the histamine-induced calcium mobilization in HeLa cells. The long residence time of bilastine is furthermore suggested to be (in part) responsible for its known long duration of action in vivo. The long duration of action is probably also influence by other parameters like the level of tissue incorporation, which was earlier reported also to affect the pharmacokinetics of antihistamines (Simons et al., 2002; Slack et al., 2011) . Hence, binding affinity measures without the context of the drug binding kinetics cannot always explain the in vivo efficacy, especially since the measured binding kinetics are required to validate the target binding affinity.
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